Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_assertion type Assertion NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_head.
- NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_assertion description "[As such, Cx43 may be involved in joint pathology during OA, and targeting Cx43 expression or function may be a viable therapeutic strategy to attenuate the catabolic and inflammatory environment of the joint during OA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_provenance.
- NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_assertion evidence source_evidence_literature NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_provenance.
- NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_assertion SIO_000772 25496568 NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_provenance.
- NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_assertion wasDerivedFrom befree-2016 NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_provenance.
- NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_assertion wasGeneratedBy ECO_0000203 NP1246929.RArVXYXu0kLWMP9L0mY0P1hkPpOevnq0Lr1tmvUp2srbw130_provenance.